An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum

Rex Devasahayam Arokia Balaya(Mayo Clinic in Arizona), Seul Kee Byeon(Mayo Clinic in Arizona), Arjun P. Athreya(Mayo Clinic in Arizona), Akhilesh Pandey(Mayo Clinic), Caroline W. Grant(Mayo Clinic), Marimuthu Sappani(Christian Medical College, Vellore), Lakshmanan Jeyaseelan(Mohammed Bin Rashid University of Medicine and Health Sciences), Roman M. Zenka(Mayo Clinic in Florida), Richard K. Kandasamy(Mayo Clinic), Partho Sen(Mayo Clinic in Arizona)
Journal of Gastroenterology
December 12, 2024
10.1007/s00535-024-02197-6
Cited by 5

Related Papers

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
|Cell|2016|1.1k
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
|Cell|2019|858
Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database
|PROTEOMICS|2005|792
NetPath: a public resource of curated signal transduction pathways
|Genome biology|2010|532
A Mass Spectrometry-based Proteomic Approach for Identification of Serine/Threonine-phosphorylated Proteins by Enrichment with Phospho-specific Antibodies
|Molecular & Cellular Proteomics|2002|385